|
Fluorothiazinon |
|
Acinetobacter Chlamydia Klebsiella Pseudomonas Salmonella |
Biofilm TTSS (Type III secretion system) Biofilm TTSS (Type III secretion system) TTSS (SPI-1 encode); TTSS (SPI-2 encode) |
Preclinical (in vivo) Preclinical (in vivo) Preclinical (in vitro) Preclinical (in vivo) Phase II trial |
Bondareva NE, et al. 2022. J Antibiot (Tokyo) Zigangirova NA, et al. 2012. Acta Naturae; Koroleva EA, et al. 2015. Biomed Res Int; Zigangirova NA, et al. 2016. J Med Microbiol Tsarenko SV, et al. 2023. J Antibiot (Tokyo) Sheremet AB, et al. 2018. Biomed Res Int Nesterenko LN, et al. 2016. J Antibiot (Tokyo); Zigangirova NA, et al. 2021. J Antibiot (Tokyo) |
|
4-chloro-N'-[(E)-(2-hydroxynaphthalen-1-yl)methylidene]benzohydrazide |
Depiction based on curated SMILES
Cl
O
OH
N
N
H
|
Chlamydia Salmonella Shigella |
TTSS (Type III secretion system) TTSS (SPI-1 encode); TTSS (SPI-2 encode) TTSS (Type III secretion system) |
Preclinical (in vitro) Preclinical (in vitro) Preclinical (in vitro) |
Muschiol S, et al. 2006. Proc Natl Acad Sci U S A Negrea A, et al. 2007. Antimicrob Agents Chemother Veenendaal AK, et al. 2009. J Bacteriol |
|
4-[(3-ethoxy-2-hydroxyphenyl)methyl]-N-(4-fluorophenyl)-5-oxo-1,3,4-thiadiazine-2-carboxamide |
Depiction based on curated SMILES
O
S
F
H
3
C
NH
O
N
N
OH
O
|
Chlamydia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Zigangirova NA, et al. 2012. Acta Naturae |
|
N'-(2-Hydroxy-3,5-dibromobenzylidene)-4-nitrobenzhydrazide |
Depiction based on curated SMILES
Br
_
O
O
+
N
OH
O
Br
N
HN
|
Chlamydia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Wolf K, et al. 2006. Mol Microbiol |
|
N-[(E)-(3-fluoro-2-hydroxyphenyl)methylideneamino]-4-nitrobenzamide |
Depiction based on curated SMILES
_
O
O
+
N
OH
O
F
N
N
H
|
Chlamydia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Dahlgren MK, et al. 2010. Bioorg Med Chem |
|
N'-[(E)-(5-bromo-2-hydroxyphenyl)methylidene]-2-phenylacetohydrazide |
Depiction based on curated SMILES
N
OH
Br
O
N
H
|
Chlamydia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Dahlgren MK, et al. 2010. Bioorg Med Chem |
|
(E)-N'-(5-Bromo-2-hydroxybenzylidene)-3-methoxybenzohydrazide |
Depiction based on curated SMILES
OH
Br
H
3
C
N
N
H
O
O
|
Chlamydia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Dahlgren MK, et al. 2010. Bioorg Med Chem |
|
N-[(E)-(5-tert-butyl-2-hydroxyphenyl)methylideneamino]-4-methylbenzamide |
Depiction based on curated SMILES
OH
CH
3
H
3
C
H
3
C
CH
3
N
N
H
O
|
Chlamydia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Dahlgren MK, et al. 2010. Bioorg Med Chem |
|
Compound 17 (internal name in literature) |
Depiction based on curated SMILES
O
S
F
F
F
CH
3
HN
O
N
N
OH
O
|
Chlamydia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Zigangirova NA, et al. 2012. Acta Naturae |
|
Compound 18 (internal name in literature) |
Depiction based on curated SMILES
N
S
O
OH
Br
N
O
F
F
F
N
H
|
Chlamydia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Zigangirova NA, et al. 2012. Acta Naturae |
|
| | |